News

Adequan® in the News



JUL, 2020
15
JUL
New Podcast Gives a Peek Behind the Barn Door of Legendary Equestrians
Melville, New York, July 15, 2020 – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), announces the launch of "Stories in Stride," a podcast that provides a glimpse into the lives and journeys of exceptional equestrians and equine professionals. Hosted by Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health, the podcast transcends disciplines to inspire and uplift everyone who shares a love of the horse.

New Podcast Gives a Peek Behind the Barn Door of Legendary Equestrians
During this time apart, “Stories in Stride” brings the horse community together through first-person accounts of success, disappointment, perseverance and hope.

Melville, New York, July 15, 2020 – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), announces the launch of "Stories in Stride," a podcast that provides a glimpse into the lives and journeys of exceptional equestrians and equine professionals. Hosted by Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health, the podcast transcends disciplines to inspire and uplift everyone who shares a love of the horse.

"The equine community is rich with amazing individuals whose stories are humbling, humorous and invigorating," Mann says. "It’s a privilege to bring them to light as a way of honoring history, addressing current challenges and highlighting an optimistic future we can shape together through our joint devotion to horses and equine sport."

Each "Stories in Stride" episode features a one-on-one conversation with an elite rider, trainer or veterinarian, including:

  • Boyd Martin, Olympic eventer
  • Bob Avila, Quarter Horse trainer
  • Rebecca Hart, Paralympic equestrian
  • JD Yates, performance horse trainer and team roper
  • Richard Mitchell, DVM, MRCVS, Dipl. ACVSMR, sport horse veterinarian and champion
  • And many more

The initial installments of "Stories in Stride" are available now, and new episodes will be released throughout the year. "Stories in Stride" can be accessed from Apple Podcasts, Google Podcasts and Spotify or your favorite podcast platform.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio under the American Regent brand. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0506 7/2020



JAN, 2020
06
JAN
Adequan® i.m. (polysulfated glycosaminoglycan) to Relaunch in Europe Following New Distributor Partnership Agreement
Shirley, N.Y., January 6, 2020 – American Regent Animal Health, a division of American Regent, Inc., manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan) for horses announces a new partnership with Animalcare Group plc to relaunch Adequan i.m. in Europe.

Adequan® i.m. (polysulfated glycosaminoglycan) to Relaunch in Europe Following New Distributor Partnership Agreement

Shirley, N.Y., January 6, 2020 – American Regent Animal Health, a division of American Regent, Inc., manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan) for horses announces a new partnership with Animalcare Group plc to relaunch Adequan i.m. in Europe.

Through the exclusive distribution agreement with American Regent Animal Health, Animalcare Group plc will work toward relaunching Adequan i.m. in Europe and selected markets following necessary regulatory approvals. Adequan i.m. has been unavailable for several years in Europe due to a supply issue that has now been fully resolved.

“We are excited to be working with American Regent Animal Health to bring this important product back to the market and look forward to relaunching it following necessary European regulatory review,” says Jenny Winter, CEO of Animalcare Group plc.

“The Animalcare partnership is an important first step in returning Adequan i.m. to veterinarians outside of North America,” says Andy Ferrigno, Head of Commercial Development for American Regent Animal Health. “We are working diligently with the team at Animalcare and regulatory officials toward a smooth relaunch in Europe, but we still have some work to do. A more definitive timeline for relaunch in Europe will be provided in the coming months.”

Adequan i.m. has been marketed in the United States for 30 years for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For more information and Full Prescribing Information, visit www.adequan.com.

About American Regent Animal Health
American Regent Animal Health, formerly known as Luitpold Animal Health, is a division of American Regent, Inc. American Regent Animal Health is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio under the American Regent brand. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

About Animalcare Group plc
Animalcare Group plc is a UK AIM listed veterinary sales and marketing organisation resulting from the merger of Animalcare and Ecuphar NV in July 2017. Animalcare operates in 32 countries in Europe and a further 16 worldwide. The company is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition. For more information, visit www.animalcaregroup.co.uk.

PP-AI-US-0326 12/2019



Let’s stay in touch.

Be the first to hear about important news and product information!
First, select the one that best describes you.
Then we'll take you to our sign-up page.

EQUINE VETERINARY
PROFESSIONAL
HORSE OWNER
AMERICAN REGENT ANIMAL HEALTH
About Us Our Brands